216 related articles for article (PubMed ID: 31836169)
1. Cerebrospinal fluid and blood lactate concentrations as prognostic biomarkers in dogs with meningoencephalitis of unknown origin.
Portero M; Martínez de Merlo E; Pérez C; Benito M; Daza MA; Fragio C
Vet J; 2019 Dec; 254():105395. PubMed ID: 31836169
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid lactate in dogs with inflammatory central nervous system disorders.
Mariani CL; Nye CJ; Tokarz DA; Green L; Lau J; Zidan N; Early PJ; Guevar J; Muñana KR; Olby NJ; Miles S
J Vet Intern Med; 2019 Nov; 33(6):2701-2708. PubMed ID: 31549740
[TBL] [Abstract][Full Text] [Related]
3. Comparison between cerebrospinal fluid and serum lactate concentrations in neurologic dogs with and without structural intracranial disease.
Benedicenti L; Gianotti G; Galban EM
Can J Vet Res; 2018 Apr; 82(2):97-101. PubMed ID: 29755188
[TBL] [Abstract][Full Text] [Related]
4. Expression of microRNAs miR-21 and miR-181c in cerebrospinal fluid and serum in canine meningoencephalomyelitis of unknown origin.
Gaitero L; Russell SJ; Monteith G; LaMarre J
Vet J; 2016 Oct; 216():122-4. PubMed ID: 27687938
[TBL] [Abstract][Full Text] [Related]
5. Effect of a constant rate infusion of cytosine arabinoside on mortality in dogs with meningoencephalitis of unknown origin.
Lowrie M; Thomson S; Smith P; Garosi L
Vet J; 2016 Jul; 213():1-5. PubMed ID: 27240905
[TBL] [Abstract][Full Text] [Related]
6. Meningoencephalitis of unknown origin: investigation of prognostic factors and outcome using a standard treatment protocol.
Lowrie M; Smith PM; Garosi L
Vet Rec; 2013 May; 172(20):527. PubMed ID: 23462382
[TBL] [Abstract][Full Text] [Related]
7. Corticosteroid monotherapy versus combined cytarabine continuous rate infusion and corticosteroid therapy in dogs with meningoencephalitis of unknown origin: A blinded, randomized, controlled trial.
Jones BS; Liebel FX; Fadda A; Martin S; Lawn R; Lazzerini K; Harcourt-Brown T
J Vet Intern Med; 2024; 38(3):1618-1625. PubMed ID: 38700360
[TBL] [Abstract][Full Text] [Related]
8. Clinical presentation, diagnostic findings, prognostic factors, treatment and outcome in dogs with meningoencephalomyelitis of unknown origin: A review.
Cornelis I; Van Ham L; Gielen I; De Decker S; Bhatti SFM
Vet J; 2019 Feb; 244():37-44. PubMed ID: 30825893
[TBL] [Abstract][Full Text] [Related]
9. A newly designed radiation therapy protocol in combination with prednisolone as treatment for meningoencephalitis of unknown origin in dogs: a prospective pilot study introducing magnetic resonance spectroscopy as monitor tool.
Beckmann K; Carrera I; Steffen F; Golini L; Kircher PR; Schneider U; Bley CR
Acta Vet Scand; 2015 Jan; 57(1):4. PubMed ID: 25637270
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein concentration has limited value in the diagnosis of meningoencephalitis of unknown origin in dogs.
Cavalerie R; Santos ACD; Leonardi H; Blond L; Beurlet S; Dumont R; Piazza S
J Am Vet Med Assoc; 2024 Apr; 262(4):481-488. PubMed ID: 38266391
[TBL] [Abstract][Full Text] [Related]
11. Assessment of oligoclonal bands in cerebrospinal fluid and serum of dogs with meningoencephalitis of unknown origin.
Prümmer JK; Stein VM; Marti E; Lutterotti A; Jelcic I; Schüpbach-Regula G; Buch T; Maiolini A
PLoS One; 2023; 18(1):e0280864. PubMed ID: 36696385
[TBL] [Abstract][Full Text] [Related]
12. Combined cytosine arabinoside and prednisone therapy for meningoencephalitis of unknown aetiology in 10 dogs.
Zarfoss M; Schatzberg S; Venator K; Cutter-Schatzberg K; Cuddon P; Pintar J; Weinkle T; Scarlett J; Delahunta A
J Small Anim Pract; 2006 Oct; 47(10):588-95. PubMed ID: 17004951
[TBL] [Abstract][Full Text] [Related]
13. Treatment of 11 dogs with meningoencephalomyelitis of unknown origin with a combination of prednisolone and cytosine arabinoside.
Menaut P; Landart J; Behr S; Lanore D; Trumel C
Vet Rec; 2008 Feb; 162(8):241-5. PubMed ID: 18296666
[TBL] [Abstract][Full Text] [Related]
14. Treatment of meningoencephalitis of unknown origin in a dog.
Behr S; Llabrés-Días FJ; Radaelli ST
Vet Rec; 2009 May; 164(20):627-9. PubMed ID: 19448257
[No Abstract] [Full Text] [Related]
15. Risk factors for early death or euthanasia within 100 days of diagnosis in dogs with meningoencephalitis of unknown origin.
Lawn RW; Harcourt-Brown TR
Vet J; 2022 Sep; 287():105884. PubMed ID: 35987308
[TBL] [Abstract][Full Text] [Related]
16. Role of
Portero M; Miró G; Checa R; Martínez de Merlo E; Fragío C; Benito M; Sainz Á; Pérez C
Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33802179
[TBL] [Abstract][Full Text] [Related]
17. Survival time and relapse in dogs with meningoencephalomyelitis of unknown origin treated with prednisolone and ciclosporin: a retrospective study.
Brady SL; Woodward AP; le Chevoir M
Aust Vet J; 2020 Oct; 98(10):491-498. PubMed ID: 32794230
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of non-infectious inflammatory CNS diseases in dogs - Where are we now? Part I: Meningoencephalitis of unknown origin.
Andersen-Ranberg E; Berendt M; Gredal H
Vet J; 2021 Jul; 273():105678. PubMed ID: 34148601
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for 1-week survival in dogs diagnosed with meningoencephalitis of unknown aetiology.
Cornelis I; Volk HA; Van Ham L; De Decker S
Vet J; 2016 Aug; 214():91-5. PubMed ID: 27387733
[TBL] [Abstract][Full Text] [Related]
20. Metagenomic Investigation of Idiopathic Meningoencephalomyelitis in Dogs.
Hoon-Hanks LL; McGrath S; Tyler KL; Owen C; Stenglein MD
J Vet Intern Med; 2018 Jan; 32(1):324-330. PubMed ID: 29197179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
